2-chloro-n(6)cyclopentyladenosine has been researched along with sphingosine kinase in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (sphingosine kinase) | Trials (sphingosine kinase) | Recent Studies (post-2010) (sphingosine kinase) |
---|---|---|---|---|---|
252 | 0 | 43 | 1,660 | 4 | 978 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, KM; D'Agati, VD; Haase, VH; Kim, JY; Kim, M; Lee, HT; Park, SW | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and sphingosine kinase
Article | Year |
---|---|
Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia.
Topics: Acute Kidney Injury; Adenosine; Adenosine A1 Receptor Agonists; Animals; Kidney; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Statistical; Phosphotransferases (Alcohol Group Acceptor); Receptor, Adenosine A1; Receptors, Lysosphingolipid; Reperfusion Injury | 2012 |